BMI_Logo-_NEW_2022.jpg

slogan2

301-378-2551
124 Byte Drive, Frederick, MD 21702

Contact Us Form

"Bringing Creativity to the Biomedical Industry"

IRT_Logo.png

IRT is the original platform technology identifies immunodominant highly divergent epitopes through bioinformatic analysis for dampening, which allows the immune system to ignore these decoy epitopes resulting in antibodies and cell-mediated responses to the more highly conserved less antigenic sites. HRV, Influenza and Covid-19 have all demonstrated improved immunogenicity using IRT. 

 

 

IRT COVVaccine project working towards a universal covid vaccine utilizing proprietary epitope prediction software and the immune refocusing lt blue sq2technology. Purpose of this project was to develop a vaccine that would better protect patients from emerging variants as the virus evolves over time. [Internally Funded]

 

IRT FLUVaccine project working towards a universal influenza vaccine utilizing proprietary epitope prediction software and immune refocusing technology. Purpose of this project was to develop a vaccine that would be broadly neutralizing allowing greater protection of circulating strains. Goal was to eliminate the need for the “hit-or-miss” approach of annual immunization. [Funded by a Phase I NIH Research Grant].

 

lt blue sq1For further information, please use our Contact Us Form